{
    "success": true,
    "data": {
        "leverage": true,
        "derivatives": true,
        "swaps": true,
        "inverse": false,
        "replication_method": "synthetic",
        "ucits": true,
        "type": "ETP",
        "complex_factors": [
            "Leverage (3x daily)",
            "Derivative use integral to strategy (FX forward contracts)",
            "Synthetic replication",
            "Compounding effect due to daily reset",
            "Roll costs implications",
            "Comprehension alert present in KID",
            "Does not meet Article 38(a) criteria due to derivative nature"
        ],
        "classification": "complex",
        "supporting_data": "This product, despite being UCITS eligible, is classified as 'complex' based on several key features outlined in the MiFID II rules and ESMA guidance. The Key Information Document (KID) itself explicitly includes a comprehension alert: 'You are about to purchase a product that is not simple and may be difficult to understand', which is a mandatory warning for complex products (Rule 7). The primary reason for complexity stems from its investment objective, which involves providing a '3 times the daily performance of FX forward contracts'. This demonstrates that derivatives (FX forward contracts) are integral to achieving its investment objective, rather than being used merely for efficient portfolio management (Rule 2). The product's reliance on these contracts for performance replication indicates a synthetic replication method, which is generally considered complex due to inherent opacity and risks like counterparty and collateral risk (Rule 3). Furthermore, the explicit '3x Daily' leverage introduces significant structural complexity. The KID highlights the 'daily reset' of the leverage factor, which leads to a 'compounding effect' and means 'the return of the product is not the same as the return of the Index multiplied by a factor of 3' over periods longer than one day. This type of leverage and its associated compounding risk, along with potential 'rolling' costs of forward contracts, are beyond the understanding of a retail investor with basic knowledge (Rule 4, Rule 5 on Leverage). The ESMA guidance (CESR/09-295, Section 4, Annex I) explicitly states that MiFID-scope derivatives (covered by items 4-10 of Section C of Annex I to MiFID) are 'ALWAYS COMPLEX', which includes forward contracts. This product fails the criterion 38(a) of the Level 2 Directive, solidifying its complex classification. The stated 'Intended Retail Investor' requiring 'specific knowledge or experience of investing in similar products' further supports this assessment."
    }
}